ATE289815T1 - Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie - Google Patents
Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämieInfo
- Publication number
- ATE289815T1 ATE289815T1 AT96945220T AT96945220T ATE289815T1 AT E289815 T1 ATE289815 T1 AT E289815T1 AT 96945220 T AT96945220 T AT 96945220T AT 96945220 T AT96945220 T AT 96945220T AT E289815 T1 ATE289815 T1 AT E289815T1
- Authority
- AT
- Austria
- Prior art keywords
- glaucoma
- medication
- preparing
- treatment
- sulfonyl compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US935195P | 1995-12-21 | 1995-12-21 | |
PCT/US1996/020197 WO1997023222A1 (en) | 1995-12-21 | 1996-12-20 | Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE289815T1 true ATE289815T1 (de) | 2005-03-15 |
Family
ID=21737108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96945220T ATE289815T1 (de) | 1995-12-21 | 1996-12-20 | Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie |
Country Status (14)
Country | Link |
---|---|
US (2) | US6271224B1 (de) |
EP (1) | EP0868186B1 (de) |
JP (1) | JP3719609B2 (de) |
KR (1) | KR100452715B1 (de) |
CN (1) | CN1155383C (de) |
AT (1) | ATE289815T1 (de) |
AU (1) | AU720326B2 (de) |
DE (1) | DE69634414T2 (de) |
ES (1) | ES2238702T3 (de) |
HK (1) | HK1015691A1 (de) |
MX (1) | MX9805033A (de) |
PT (1) | PT868186E (de) |
TW (1) | TW534814B (de) |
WO (1) | WO1997023222A1 (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6699508B1 (en) * | 1998-08-10 | 2004-03-02 | Asahi Kasei Pharma Corporation | Sustained release oral preparations of fasudil hydrochloride |
CA2307285C (en) | 1998-08-17 | 2009-03-31 | Senju Pharmaceutical Co., Ltd. | Agent for prophylaxis and treatment of glaucoma |
WO2000057914A1 (fr) * | 1999-03-25 | 2000-10-05 | Santen Pharmaceutical Co., Ltd. | Agents permettant d'abaisser la tension oculaire |
AU4144400A (en) | 1999-04-27 | 2000-11-10 | Mitsubishi Pharma Corporation | Preventives/remedies for liver diseases |
EP1064944A1 (de) * | 1999-06-25 | 2001-01-03 | Schering Aktiengesellschaft | Protein-Kinase N Hemmer enthaltend Fasudil |
WO2002083175A1 (fr) | 2001-04-11 | 2002-10-24 | Senju Pharmaceutical Co., Ltd. | Agents ameliorant la fonction visuelle |
BR0215149A (pt) * | 2001-12-21 | 2004-10-19 | Alcon Inc | Uso de nanopartìculas inorgânicas para modificar a viscosidade e outras propriedades fìsicas de composições farmacêuticas e óticas |
US20050003014A1 (en) * | 2001-12-21 | 2005-01-06 | Ketelson Howard Allen | Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
ES2382733T3 (es) * | 2002-08-29 | 2012-06-13 | Santen Pharmaceutical Co., Ltd. | Remedio para el glaucoma que comprende un inhibidor de la Rho quinasa y prostaglandinas |
KR101103141B1 (ko) * | 2002-11-18 | 2012-01-04 | 산텐 세이야꾸 가부시키가이샤 | Rho 키나아제 억제제와 β 차단약으로 이루어진 녹내장치료제 |
EP1550446A1 (de) * | 2003-11-14 | 2005-07-06 | Switch Biotech Aktiengesellschaft | Verwendung von 1-(5-Isochinolinsulfonyl)homopiperazin zur Behandlung und Vorbeugung von Hypopigmentstörungen |
WO2004096222A1 (en) * | 2003-04-30 | 2004-11-11 | Switch Biotech Ag | Use of 1-(5-isoquinolinesulfonyl)homopiperazine, its active metabolites, isomers and salts for treating and preventing hypopigmentary disorders |
TWI344961B (en) | 2003-10-15 | 2011-07-11 | Ube Industries | Novel indazole derivative |
WO2005063249A1 (en) * | 2003-12-22 | 2005-07-14 | Alcon, Inc. | Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration |
TW200526224A (en) * | 2003-12-22 | 2005-08-16 | Alcon Inc | Short form c-Maf transcription factor antagonists for treatment of glaucoma |
CN1897972A (zh) * | 2003-12-22 | 2007-01-17 | 爱尔康公司 | 用于治疗青光眼性视网膜病和视神经病的活性剂 |
KR101194123B1 (ko) | 2004-03-16 | 2012-10-24 | 아사히 가세이 파마 가부시키가이샤 | 패수딜 함유 제제 및 그 안정성을 개선하는 방법 |
US20080096238A1 (en) * | 2004-03-30 | 2008-04-24 | Alcon, Inc. | High throughput assay for human rho kinase activity with enhanced signal-to-noise ratio |
US20060115870A1 (en) * | 2004-03-30 | 2006-06-01 | Alcon, Inc. | High throughput assay for human Rho kinase activity |
WO2005102345A1 (en) * | 2004-03-30 | 2005-11-03 | Alcon, Inc. | Use of rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance |
TWI367098B (en) * | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
US20060142270A1 (en) * | 2004-12-23 | 2006-06-29 | Kowa Co., Ltd. | Preventing or treating agent for glaucoma |
CA2590261C (en) * | 2004-12-27 | 2011-08-16 | Alcon, Inc. | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions |
KR101333970B1 (ko) | 2005-05-19 | 2013-11-27 | 코와 가부시키가이샤 | 녹내장 예방 또는 치료제 |
RU2376300C1 (ru) * | 2005-08-30 | 2009-12-20 | Асахи Касеи Фарма Корпорэйшн | Сульфонамидное соединение |
CN100367967C (zh) * | 2005-12-12 | 2008-02-13 | 天津红日药业股份有限公司 | 一种盐酸法舒地尔口服制剂 |
RU2008130111A (ru) * | 2005-12-22 | 2010-01-27 | Алькон Рисерч, Лтд. (Us) | (индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний |
US7867999B1 (en) | 2005-12-22 | 2011-01-11 | Alcon Research, Ltd. | Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions |
TW200815398A (en) | 2006-06-08 | 2008-04-01 | Ube Industries | A novel indazole derivative having spirocyclic structure in the side chain |
US20080064681A1 (en) * | 2006-09-11 | 2008-03-13 | Hiroyoshi Hidaka | Therapeutic agent for treating glaucoma |
AR064420A1 (es) * | 2006-12-21 | 2009-04-01 | Alcon Mfg Ltd | Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop). |
WO2008105058A1 (ja) * | 2007-02-27 | 2008-09-04 | Asahi Kasei Pharma Corporation | スルホンアミド化合物 |
EP2130828A4 (de) | 2007-02-28 | 2010-12-29 | Asahi Kasei Pharma Corp | Sulfonamidderivat |
WO2009004792A1 (ja) | 2007-07-02 | 2009-01-08 | Asahi Kasei Pharma Corporation | スルホンアミド化合物及びその結晶 |
US20120101167A1 (en) * | 2010-10-25 | 2012-04-26 | Langham Maurice E | Treatment of ocular and cerebral ischemia |
CN102028694B (zh) * | 2010-11-12 | 2012-03-14 | 天津红日药业股份有限公司 | 法舒地尔经眼部给药用于制备治疗青光眼药物中的应用 |
PL2657227T3 (pl) * | 2010-12-22 | 2016-09-30 | Nowa podstawiona pochodna izochinoliny | |
TW201729813A (zh) | 2011-02-04 | 2017-09-01 | Kowa Co Ltd | 青光眼預防或治療之藥物療法 |
CN102138895B (zh) * | 2011-03-30 | 2013-01-23 | 天津红日药业股份有限公司 | 一种含盐酸法舒地尔的滴眼剂及其制备 |
EP2696872B1 (de) * | 2011-04-01 | 2019-01-16 | Indiana University Research and Technology Corporation | Behandlung von glaukomen |
JP2013035802A (ja) * | 2011-08-10 | 2013-02-21 | D Western Therapeutics Institute Inc | 緑内障又は高眼圧症の予防又は治療剤 |
JP2013129605A (ja) * | 2011-12-20 | 2013-07-04 | Kowa Co | 緑内障治療薬を含有する安定なフィルム製剤 |
JP2013129604A (ja) * | 2011-12-20 | 2013-07-04 | Kowa Co | 緑内障治療薬を含有する徐放性フィルム製剤 |
EP2628482A1 (de) | 2012-02-17 | 2013-08-21 | Academisch Medisch Centrum | Rho Kinase Inhibitoren in der Verwendung zur Behandlung von Neuroblastoma |
JP5557408B1 (ja) * | 2013-04-24 | 2014-07-23 | 国立大学法人九州大学 | 眼底疾患治療剤 |
MX2018003528A (es) * | 2015-09-25 | 2018-11-09 | Okogen Inc | Tratamiento de conjuntivitis viral utilizando ranpirnasa y/o anfinasa. |
WO2017064119A1 (en) * | 2015-10-13 | 2017-04-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion |
EP4088719A1 (de) * | 2015-10-13 | 2022-11-16 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Verfahren und pharmazeutische zusammensetzungen zur behandlung von kapillarer nichtperfusion der netzhaut |
CA3082643A1 (en) | 2017-11-14 | 2019-05-23 | The Schepens Eye Research Institute, Inc. | Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition |
US11446273B2 (en) | 2017-12-21 | 2022-09-20 | Santen Pharmaceutical Co., Ltd. | Medicament comprising combination of sepetaprost and Rho-associated coiled-coil containing protein kinase inhibitor |
EP3843845A4 (de) | 2018-08-29 | 2022-05-11 | University Of Massachusetts | Hemmung von proteinkinasen zur behandlung von friedreich-ataxie |
EP4204414A1 (de) * | 2020-08-31 | 2023-07-05 | Viewpoint Therapeutics, Inc. | Verbindungen und formulierungen zur behandlung von augenerkrankungen |
CA3207859A1 (en) | 2021-01-11 | 2022-07-14 | Incyte Corporation | Combination therapy comprising jak pathway inhibitor and rock inhibitor |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4456757A (en) | 1981-03-20 | 1984-06-26 | Asahi Kasei Kogyo Kabushiki Kaisha | Isoquinolinesulfonyl derivatives and process for the preparation thereof |
NZ200429A (en) | 1981-04-30 | 1984-10-19 | Smith & Nephew Ass | Applicator for placing pharmaceutically active agent in contact with moist surface,e.g.,eye |
US4730013A (en) | 1981-10-08 | 1988-03-08 | Merck & Co., Inc. | Biosoluble ocular insert |
US4678783B1 (en) | 1983-11-04 | 1995-04-04 | Asahi Chemical Ind | Substituted isoquinolinesulfonyl compounds |
US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
AU4246793A (en) | 1992-05-13 | 1993-12-13 | Alcon Laboratories, Inc. | Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
US5922773A (en) | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
JP3683908B2 (ja) | 1993-10-13 | 2005-08-17 | アラーガン、インコーポレイテッド | (2−イミダゾリン−2−イルアミノ)キノキサリン誘導体の使用方法 |
KR960701033A (ko) | 1993-12-08 | 1996-02-24 | 그레그 씨.브라운 | 효능있는 칼슘 길항 및 산화방지 활성을 모두 갖는 화합물, 및 세포보호제로서 그것의 사용방법(compounds having both potent calcium antagonist and antioxidant activity and use there of as cytoprotective agents) |
EP0741709B1 (de) | 1994-01-24 | 2001-07-25 | Allergan Sales, Inc. | Aromatische 2-amino-imidazolderivate als alpha 2a-adrenoceptor agonisten |
JPH07277979A (ja) | 1994-04-12 | 1995-10-24 | Asahi Chem Ind Co Ltd | 過粘性症候群治療または予防剤 |
US5602143A (en) | 1994-12-08 | 1997-02-11 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors |
US5573758A (en) | 1995-04-28 | 1996-11-12 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
US5798380A (en) | 1996-02-21 | 1998-08-25 | Wisconsin Alumni Research Foundation | Cytoskeletal active agents for glaucoma therapy |
-
1996
- 1996-12-20 EP EP96945220A patent/EP0868186B1/de not_active Expired - Lifetime
- 1996-12-20 ES ES96945220T patent/ES2238702T3/es not_active Expired - Lifetime
- 1996-12-20 KR KR10-1998-0704649A patent/KR100452715B1/ko not_active IP Right Cessation
- 1996-12-20 PT PT96945220T patent/PT868186E/pt unknown
- 1996-12-20 JP JP52379397A patent/JP3719609B2/ja not_active Expired - Fee Related
- 1996-12-20 CN CNB961996730A patent/CN1155383C/zh not_active Expired - Fee Related
- 1996-12-20 AU AU14644/97A patent/AU720326B2/en not_active Ceased
- 1996-12-20 DE DE69634414T patent/DE69634414T2/de not_active Expired - Fee Related
- 1996-12-20 WO PCT/US1996/020197 patent/WO1997023222A1/en active IP Right Grant
- 1996-12-20 AT AT96945220T patent/ATE289815T1/de not_active IP Right Cessation
- 1996-12-20 US US09/077,575 patent/US6271224B1/en not_active Expired - Fee Related
-
1997
- 1997-02-04 TW TW086101346A patent/TW534814B/zh not_active IP Right Cessation
-
1998
- 1998-06-19 MX MX9805033A patent/MX9805033A/es not_active IP Right Cessation
-
1999
- 1999-02-27 HK HK99100710D patent/HK1015691A1/xx not_active IP Right Cessation
-
2001
- 2001-07-31 US US09/919,301 patent/US6403590B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69634414D1 (de) | 2005-04-07 |
JP3719609B2 (ja) | 2005-11-24 |
TW534814B (en) | 2003-06-01 |
HK1015691A1 (en) | 1999-10-22 |
MX9805033A (es) | 1998-09-30 |
ES2238702T3 (es) | 2005-09-01 |
AU720326B2 (en) | 2000-05-25 |
WO1997023222A1 (en) | 1997-07-03 |
CN1155383C (zh) | 2004-06-30 |
US6271224B1 (en) | 2001-08-07 |
CN1207680A (zh) | 1999-02-10 |
JP2001509780A (ja) | 2001-07-24 |
PT868186E (pt) | 2005-05-31 |
KR19990076580A (ko) | 1999-10-15 |
KR100452715B1 (ko) | 2004-12-17 |
US6403590B1 (en) | 2002-06-11 |
DE69634414T2 (de) | 2005-11-17 |
EP0868186B1 (de) | 2005-03-02 |
EP0868186A1 (de) | 1998-10-07 |
AU1464497A (en) | 1997-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE289815T1 (de) | Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie | |
Krachmer | Pellucid marginal corneal degeneration | |
DK112190A (da) | Prostaglandinderivater til behandling af glaukom eller foroeget okulaert tryk | |
ATE286880T2 (de) | Verwendung von fluprostenolisopropylester zur herstellung eines arzneimittels zur behandlung von glaukom und okularer hypertension | |
DE69521620D1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
DE3872701T2 (de) | Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck. | |
DE69930271T8 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
HK1045645A1 (zh) | 消除角膜瘢痕、渾濁化和混濁的生化方法 | |
ATE309796T1 (de) | Verfahren zur behandlung von augenerkrankungen | |
DE69829062D1 (de) | Verwendung von flunarizin zur topischen behandlung ocularem hochdruck | |
ATE213634T1 (de) | Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts | |
Davenport et al. | Loss of sight following snake bite | |
EP0345028A3 (de) | Verwendung eines Phosphodiesterase-Inhibitors zur Glaukombehandlung | |
SU1342500A1 (ru) | Способ лечени глаукомы | |
CA2240271A1 (en) | Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia | |
Smith | The blood-aqueous barrier in hydrophthalmic rabbits | |
SU1251898A1 (ru) | Способ лечени птоза верхнего века | |
BROWN | DR. WM. L. NOBI, E, President. | |
RU93025693A (ru) | Способ хирургического лечения близорукости | |
O’Reilly | Gormaz, A. and Eggers, C. Scheie’s op-eration for glaucoma. Arch. chil. de oftal. 16: 25-31, Jan.-June, 1959. The author describes his experience with Scheie’s operation which consists of | |
Moore et al. | Brooklyn Ophthalmological Society | |
SORSBY | graphy of the eye, and discusses some optical and physiological difficulties. | |
Hiwatari | Detaching of bulbar conjunctiva as a treatment of trachomatous pannus | |
JO1317B1 (en) | Eye treatment | |
RU2001121429A (ru) | Способ лечения поражений роговицы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0868186 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |